hepatocellular carcinoma
Conditions
Interventions
Sponsors
Zhongshan hospital, Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: ? Patients diagnosed with HCC and proposed to undergo target-immunity combination therapy ? Conventional ultrasound, elastic ultrasound and ultrasonography were performed within one week prior to the start of target-immunity combination therapy ? Conventional ultrasound, elastic ultrasound and ultrasonography were performed within one week after the end of each course of target-free combination therapy
Exclusion criteria
Exclusion criteria: ? patients who have received other comprehensive treatment (e.g. chemotherapy, radiotherapy, local intervention, etc.) before target-free combination therapy ? Patients who are unable to obtain pathological data to determine whether pathological remission has been achieved after target-immunity combination therapy ? Patients who have interrupted the target-immunity combination therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Multimodal ultrasound diagnostic results;Artificial Intelligence Network Model;AUC;accuracy;sensitivity;specificity; | — |
Countries
China
Contacts
Public ContactHuixiong Xu
Zhongshan hospital, Fudan University
Outcome results
None listed